img

Global Fibrinogen Concentrates Market Size By Product (Animal Fibrinogen Concentrates, Human Fibrinogen Concentrate), By Application (Congenital Fibrinogen Deficiency, Surgical Procedures), By Geographic Scope And Forecast


Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report

Publisher : MIR | Format : PDF&Excel

Global Fibrinogen Concentrates Market Size By Product (Animal Fibrinogen Concentrates, Human Fibrinogen Concentrate), By Application (Congenital Fibrinogen Deficiency, Surgical Procedures), By Geographic Scope And Forecast

Fibrinogen Concentrates Market Size And Forecast

Fibrinogen Concentrates Market size was valued at USD 3.11 Billion in 2024 and is projected to reach USD 4.63 Billion by 2031, growing at a CAGR of 5.64% during the forecast period 2024-2031.

The Fibrinogen Concentrates Market is expected to show considerable growth owing to increasing blood-related disorders among people and growing acceptance of people for Fibrinogen Concentrate. The Global Fibrinogen Concentrates Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Fibrinogen Concentrates Market Definition

Fibrinogen is a glycoprotein present in the blood plasma and this is produced by the liver. Fibrinogen is present in the vertebrates which helps in the formation of a blood clot, sometimes blood clot is formed inside the blood vessels because of a low level of fibrinogen which leads to thrombosis and this interrupts the normal blood flow through the circulatory system. It is also helpful for making medicines for the disease-related blood. Thrombosis is an infrequent bleeding disorder that can be characterized by mild to critical forms of bleeding. The three forms of fibrinogen deficiency are hypofibrinogenemia, afibrinogenemia, and dysfibrinogenemia. When the patient is heavily bleeding the fibrinogen concentration enhances the whole blood clot rigidness and decreases the postoperative transfusion requirements.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Fibrinogen Concentrates Market Overview

In this competitive world, there is increasing stress among the people due to changes in their lifestyle as a result of this there is an increase in blood-related disorders, Congenital Fibrinogen is estimated to hold the largest share of this market which results in a better occurrence of hemophilia and better fibrinogen products. Increasing the use of fibrinogen concentrates for patients with the disease-related to bleeding such as congenital deficiencies is the primary factor driving the growth of this market. Nowadays people are more aware of their health and consider health their first priority is another important factor driving the growth of this market.

Presently, instead of traditional fibrinogen sources including frozen plasma or cryoprecipitate, Fibrinogen Concentrate is broadly being accepted by the people along with the firms. The Fibrinogen Concentrates Market is increasing due to the growing patient population and use of various surgical procedures which has led to the increased demand for Fibrinogen. Moreover, The Fibrinogen concentrates are being utilized to prepare anti-coagulates which are used in the treatment of congenital afibrinogenemia, dysfibrinogenemia, hypofibrinogenemia, and others.

Global Fibrinogen Concentrates MarketSegmentation Analysis

The Global Fibrinogen Concentrates Market is Segmented on the basis of Product, Application, and Geography.

Fibrinogen Concentrates Market, By Product

  • Animal Fibrinogen Concentrates
  • Human Fibrinogen Concentrate

Based on Product, the market is segmented into Animal Fibrinogen Concentrates and Human Fibrinogen Concentrate. Human Fibrinogen Concentrate is estimated to hold the largest share of this segment during the forecasted period due to the increasing requirement for fibrinogen concentrate to treat bleeding disorders and congenital coagulation deficiencies.

Fibrinogen Concentrates Market, By Application

  • Congenital Fibrinogen Deficiency
  • Surgical Procedures

Based on Application, the market is segmented into Congenital Fibrinogen Deficiency and Surgical Procedures. Congenital Fibrinogen is estimated to show the highest growth during the forecasted period owing to high incidences of hemophilia and increasing bleeding disorders among people. The safety proven by fibrinogen concentrates and advancements in fibrinogen products has also led to the growth of this segment in the Fibrinogen Concentrates Market.

Fibrinogen Concentrates Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of regional analysis, the Global Fibrinogen Concentrates Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is estimated to hold the largest share of this market because of the increasing burden of bleeding disorders and growing geriatric population and acquired hemophilia which is a rare autoimmune disorder is foremost in the geriatric population and a disease called Von Willebrand is one of the most common bleeding disorder which affects almost 1% of the population every year in the United States. These are the major factors contributing to the growth of the Fibrinogen Concentrates Market in this region.

Key Players

The “Global Fibrinogen Concentrates Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are CSL Behring, LFB Group, ProFibix BV, Baxter International Inc., Hualan Biological Engineering, Harbin Pacific Biopharmaceutical Co. Ltd, Green Cross Limited, and Shanghai Xinxing Medicine Co. Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • December 2021 – LFB plasma which is a part of LFB Group announced its acquisition of Immuno Tek Bio Centre in Florence, South California. LFB Group is a global biopharmaceutical company that develops and provides plasma-derived and recombinant products through its innovative technologies.
  • January 2022 – GC Cell and Rivaara Immune Private Limited announced that they are about to enter into an exclusive licensing agreement, Rivaara Immune has agreed to develop and commercialize Immunecell-LC.

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2021-2031

Base Year

2024

Forecast Period

2024-2031

Historical Period

2021-2023

Unit

Value (USD Billion)

Key Companies Profiled

CSL Behring, LFB Group, ProFibix BV, Baxter International Inc., Hualan Biological Engineering, Harbin Pacific Biopharmaceutical Co. Ltd, Green Cross Limited

Segments Covered
  • By Product
  • By Application
  • By Geography
Customization Scope

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )